Neogen Corp (NEOG) — Analysis Summary
Neogen Corp (NEOG) has a market cap of $2.10B with year-over-year revenue growth of -3.2%. Net margin stands at -122.1%. The stock trades at a P/E ratio of -3.5.
Key Takeaways
- Revenue changed -3.2% year-over-year
- Net margin of -122.1%
- P/E ratio of -3.5
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, NEOG posted revenue growth of -3.2% and trades at a P/E of -3.5.
Neogen Corp (NEOG)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -16.7x — earnings do not cover interest payments
Operating margin at -73.0% — severe operating losses
Net margin at -69.9% — significant losses
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Sector
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
1,456
Headquarters
LANSING, MI
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.